ANTIHYPERTENSIVE THERAPY IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which have nephroprotective effects, are first-line drugs (FL) for treatment of arterial hypertension (AH) in patients with chronic kidney disease (CKD). However, these groups of drugs have a number of contraindications, certain adverse drug reactions, unwanted drug interactions and therefore cannot be prescribed in all AH patients with CKD. Therefore, real clinical practice studies are needed to assess the real frequency of nephroprotective drugs prescription, especially in the elderly.